No Data
12 Health Care Stocks Moving In Friday's Pre-Market Session
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating, Announces Target Price $3
Craig-Hallum analyst William Bonello maintains $Biodesix(BDSX.US)$ with a buy rating, and sets the target price at $3.According to TipRanks data, the analyst has a success rate of 72.5% and a total
Biodesix Analyst Ratings
Scotiabank Maintains Biodesix(BDSX.US) With Buy Rating, Cuts Target Price to $3
Scotiabank analyst Sung Ji Nam maintains $Biodesix(BDSX.US)$ with a buy rating, and adjusts the target price from $10 to $3.According to TipRanks data, the analyst has a success rate of 49.6% and a
Scotiabank Initiates Biodesix at Sector Outperform With $3 Price Target
Biodesix to Present at Two Investor Conferences in September